Evidence map›Paper›PMID 33380736›Full record

ArticleScientific reports2020

Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample types.

R A Barclay, I Akhrymuk, A Patnaik, V Callahan, C Lehman, P Andersen, R Barbero, S Barksdale, R Dunlap, D Goldfarb and 14 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Comparing SARS-CoV-2 Viral Load in Human Saliva to Oropharyngeal Swabs, Nasopharyngeal Swabs, and Sputum: A Systematic Review and Meta-Analysis.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  8. Review
  9. Article
  10. Hydrogels and Their Role in Biosensing Applications.Advanced healthcare materials · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 2 institutions in 1 country.

R A BarclayCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
I AkhrymukNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
A PatnaikCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
V CallahanNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
C LehmanNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
P AndersenCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
R BarberoCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
S BarksdaleCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
R DunlapCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
D GoldfarbCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
T Jones-RoeCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
R KellyCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
B KimCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
S MiaoCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
A MunnsCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
D MunnsCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
S PatelCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
E PorterCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
R RamseyCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
S SahooCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
O SwahnCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
J WarshCeres Nanosciences, Inc., Manassas, VA, 20110, USA.
K Kehn-HallNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
B LepeneCeres Nanosciences, Inc., Manassas, VA, 20110, USA. blepene@ceresnano.com.
Ceres Nanosciences · USGeorge Mason University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we present a rapid and versatile method for capturing and concentrating SARS-CoV-2 from contrived transport medium and saliva samples using affinity-capture magnetic hydrogel particles. We demonstrate that the method concentrates virus from 1 mL samples prior to RNA extraction, substantially improving detection of virus using real-time RT-PCR across a range of viral titers (100-1,000,000 viral copies/mL) and enabling detection of virus using the 2019 nCoV CDC EUA Kit down to 100 viral copies/mL. This method is compatible with commercially available nucleic acid extraction kits (i.e., from Qiagen) and a simple heat and detergent method that extracts viral RNA directly off the particle, allowing a sample processing time of 10 min. We furthermore tested our method in transport medium diagnostic remnant samples that previously had been tested for SARS-CoV-2, showing that our method not only correctly identified all positive samples but also substantially improved detection of the virus in low viral load samples. The average improvement in cycle threshold value across all viral titers tested was 3.1. Finally, we illustrate that our method could potentially be used to enable pooled testing, as we observed considerable improvement in the detection of SARS-CoV-2 RNA from sample volumes of up to 10 mL.

Indexed as

COVID-19COVID-19 TestingDiagnostic Tests, RoutineHumansHydrogelsNasopharynxReal-Time Polymerase Chain ReactionRNA, ViralSalivaSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingViral LoadHydrogelsRNA, Viral

Identifiers

PMID33380736
PMCPMC7773739
OpenAlexW3118151404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.